| 14 |
Räihä J, Helanterä I, Ekstrand A, et al. Effect of pretransplant dialysis modality on outcomes after simultaneous pancreas-kidney transplantation[J]. Ann Transplant, 2019, 24: 426-431.
|
| 15 |
Jiang FX, Morahan G. Pancreatic stem cells remain unresolved[J]. Stem Cells Dev, 2014, 23(23): 2803-2812.
|
| 16 |
Anazawa T, Okajima H, Masui T, et al. Current state and future evolution of pancreatic islet transplantation[J]. Ann Gastroenterol Surg, 2018, 3(1): 34-42.
|
| 17 |
Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients[J]. The Lancet, 1994, 344(8934): 1402-1404.
|
| 18 |
Castaing M, Peault B, Basmaciogullari A, et al. Blood glucose normalization upon transplantation of human embryonic pancreas into bata-cell deficient SCID mice[J]. Diabetologia, 2001, 44(11): 2066-2067.
|
| 19 |
Gittes GK, Galante PE, Hanrahan D, et al. Lineage-specific morphogenesis in the developing pancreas: role of mesenchymal factors[J]. Development, 1996, 122(2): 439-447.
|
| 20 |
Brown J, Danilovs JA, Clark WR, et al. Fetal pancreas as a donor organ[J]. World J Surg, 1984, 8(2): 152-157.
|
| 21 |
Brown J, Mullen YS, Clark WR, et al. Importance of hepatic portal circulation for insulin action in streptozotocin-diabetic rats transplanted with fetal pancreases[J]. J Clin Invest, 1979, 64(6): 1688-1694.
|
| 22 |
Brown J, Heininger D, Kuret J, et al. Islet cells grow after transplantation of fetal pancreas and control of diabetes[J]. Diabetes, 1981, 30(1): 9-13.
|
| 23 |
Brown J, Clark WR, Molnar IG, et al. Fetal pancreas transplantation for reversal of streptozotocin diabetes in rats[J]. Diabetes, 1976, 25(1): 56-64.
|
| 24 |
Hegre OD, Leonard RJ, Schmitt RV, et al. Isotransplantation of organ-culture neonatal pancreas: reversal of alloxan diabetes in the rat[J]. Diabetes, 1976, 25(3): 180-189.
|
| 25 |
Leonard RL, Lazarow A, Hegre OH. Pancreatic islet transplantation in the rat[J]. Diabetes, 1973, 22(6): 413-428.
|
| 26 |
Du Toit D, Muller C, Page B, et al. Foetal rat pancreatic transplantation: post-transplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine-based immunesuppression[J]. Microsc Res Techniq, 1998, 43(4): 347-355.
|
| 27 |
Adams GA, Squires EC, Maestri M, et al. Regimens of IGF-1 treatment in fetal pancreas transplantation[J]. J Surg Res, 1997, 68(1): 73-78.
|
| 28 |
Wang L, Huang YB, Chen G, et al. Organogenesis of pancreatic anlagen allografted in rats[J]. Transplant Proc, 2006, 38(10): 3280-3282.
|
| 29 |
Hammerman MR. Organogenesis of endocrine pancreas from transplanted embryonic anlagen[J]. Transplant Immunology, 2004, 12: 249-258.
|
| 30 |
Rogers SA, Liapis H, Hammerman MR. Intraperitoneal transplantation of pancreatic anlagen[J]. ASAIO J, 2003, 49(5): 527-532.
|
| 31 |
Hammerman MR. Underpinnings of cellular organ replacement therapies[J]. Curr Opin Organ Transplant, 2014, 19(2): 131-132.
|
| 32 |
Soria B, Andrau E, Berna G, et al. Engineering pancreatic islets[J]. Pflugers Arch-Eur J Physiol, 2000, 440(1): 1-18.
|
| 33 |
Mullen Y, Shintaku IP. Fetal pancreas allografts for reversal of diabetes in rats. Ⅰ. Allograft survival in nonimmunosuppressed recipients[J]. Transplantation, 1980, 29(1): 35-42.
|
| 34 |
Wennberg L, Song Z, Bennet W, et al. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil and leflunomide remain normoglycemic for up to 100 days[J]. Transplantation, 2001, 719(9): 1024-1033.
|
| 35 |
Korsgren O, Jansson L. Discordant cellular xenografts revascularized in intermediate athymic hosts fail to induce a hyperacute rejection when transplanted into immunocompetent rats[J]. Transplantation, 1994, 57(9): 1408-1411.
|
| 36 |
Rogers SA, Chen F, Talcott M, et al. Islet cell engraftment and control of diabetes in rats after transplantation of pig pancreatic anlagen[J]. Am J Physiol Endocrinol Metab, 2004, 286(4): E502-E509.
|
| 37 |
Rogers SA, Liapis H, Hammerman MR. Normalization of glucose post-transplantation of pig pancreatic anlagen into non-immunosuppressed diabetic rats depends on obtaining anlagen prior to embryonic day 35[J]. Transpl Immunol, 2005, 14(2): 67-75.
|
| 38 |
Rogers SA, Chen F, Talcott M, et al. Glucose tolerance normalization following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic ZDF rats[J]. Transpl Immunol, 2006, 16(3-4): 176-184.
|
|
Rogers SA, Chen F, Talcott MR, et al. Long-term engraftment following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic rhesus macaques[J]. Xenotransplantation, 2007, 14(6): 591-602.
|
| 39 |
Hammerman MR. Organogenesis of kidney and endocrine pancreas: the window opens[J]. Organogenesis, 2007, 3(2): 59-66.
|
| 40 |
Rogers SA, Hammerman MR. Normalization of glucose post-transplantation into diabetic rats of pig pancreatic primordia preserved in vitro[J]. Organogenesis, 2008, 4(1): 48-51.
|
| 41 |
Rogers SA, Mohanakumar T, Liapis H, et al. Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats[J]. Am J Pathol, 2010, 177(2): 854-864.
|
| 42 |
Rogers SA, Tripathi P, Mohanakumar T, et al. Engraftment of cells from porcine islets of Langerhans following transplantation of pig pancreatic primordia in non-immunosuppressed diabetic rhesus macaques[J]. Organogenesis, 2011, 7(3): 154-162.
|
| 1 |
Hu R, Liu Y, Su M, et al. Transplantation of donor-origin mouse embryonic stem cell-derived thymic epithelial progenitors prevents the development of chronic graft-versus-host disease in mice[J]. Stem Cells Transl Med, 2017，6(1): 121-130.
|
| 2 |
Kim MJ, Lee Y, Jon S, et al. PEGylated bilirubin nanoparticle as ananti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation[J]. Biomaterials, 2017，133: 242-252.
|
| 3 |
Hani H, Allaudin ZN, Mohd-Lila MA, et al. Caprine pancreaticislet xenotransplantation into diabetic immunosuppressed BALB/c mice[J]. Xenotransplantation, 2014, 21(2): 174-182.
|
| 4 |
Perez-Basterrechea M, Obaya AJ, Meana A, et al. Cooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantation[J]. PLoS One, 2013, 8(8): e73526.
|
| 5 |
Hammerman MR. Xenotransplantation of pancreatic and kidney primordia-where do we stand？[J]. Transpl Immunol, 2009, 21(2): 93-100.
|
| 6 |
Hammerman MR. Development of a novel xenotransplantation strategy for treatment of diabetes mellitus in rat hosts and translation to non-human primates[J]. Organogenesis, 2012, 8(2): 41-48.
|
| 7 |
Hammerman MR. Classic and current opinion in embryonic organ transplantation[J]. Curr Opin Organ Transplant, 2014, 19(2): 133-139.
|
| 8 |
Foglia RP, LaQuaglia M, Statter MB, et al. Fetal allograft survival in immunocompetent recipients is age dependent and organ specific[J]. Ann Surg, 1986, 204(7): 402-410.
|
| 9 |
Dekel B, Burakova T, Ben-Hur H, et al. Engraftment of human kidney tissue in rat radiation chimera: Ⅱ human fetal kidneys display reduced immunogenicity to adoptively trandferred human peripheral blood mononuclear cells and exhibit rapid growth and development[J]. Transplantation, 1997, 64(11): 1550-1558.
|
| 10 |
Statter M, Fahrner KJ, Barksdale EM, et al. Correlation of fetal kidney and testis congenic graft survival with reduced major histocompatibility complex burden[J]. Transplantation, 1989, 47(4): 651-660.
|
| 11 |
Dekel B, Marcus H, Herzel BH, et al. In vivo modulation of the allogeneic immune response by human fetal kidneys: the role of cytokines, chemokines, and cytolytic effector molecules[J]. Transplantation, 2000, 69(7): 1470-1478.
|
| 12 |
Hammerman MR. Engraftment of insulin-producing cells from porcine islets in non-immune-suppressed rats or nonhuman primates transplanted previously with embryonic pig pancreas[J]. J Transplant, 2011: 261352.
|
| 13 |
Thivolet C. New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies[J]. Clin Endocrinol, 2001, 55(5): 565-574.
|